Is nucleic acid amplification point-of-care testing for chlamydia and gonorrhoea cost-effective?
- PMID: 24431187
- DOI: 10.1136/sextrans-2013-051428
Is nucleic acid amplification point-of-care testing for chlamydia and gonorrhoea cost-effective?
Keywords: CHLAMYDIA INFECTION; GONORRHOEA; PELVIC INFLAMMATORY DISEASE.
Comment on
-
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England.Sex Transm Infect. 2014 Mar;90(2):104-11. doi: 10.1136/sextrans-2013-051147. Epub 2013 Nov 22. Sex Transm Infect. 2014. PMID: 24273127 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical